HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin - Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de; Ribeiro-Silva, Alfredo; Tiezzi, Marcelo Guimarães; Marana, Heitor Ricardo Cosinski; Zola, Fábio Eduardo; Sarmento-Filho, Joaquim Moraes (Congresso Brasileiro de Patologia, 2005)